B. G. Den-hoogen, S. Herfst, L. Sprong, P. A. Cane, E. Forleo-neto et al., Antigenic and genetic variability of human metapneumoviruses, Emerg. Infect. Dis, vol.10, pp.658-666, 2004.

F. Feuillet, B. Lina, M. Rosa-calatrava, and G. Boivin, Ten years of human metapneumovirus research, J. Clin. Virol, vol.53, pp.97-105, 2012.

J. Papenburg and G. Boivin, The distinguishing features of human metapneumovirus and respiratory syncytial virus, Rev. Med. Virol, vol.20, pp.245-260, 2010.

B. Rima, P. Collins, A. Easton, R. Fouchier, G. Kurath et al., Virus Taxonomy Profile: Pneumoviridae. J. Gen. Virol, vol.98, pp.2912-2913, 2017.

N. I. Mazur, D. Higgins, M. C. Nunes, J. A. Melero, A. C. Langedijk et al., The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates, Lancet Infect. Dis, vol.18, pp.295-311, 2018.

V. A. Marquez-escobar, Current developments and prospects on human metapneumovirus vaccines, Expert Rev. Vaccines, vol.16, pp.419-431, 2017.

M. E. Hamelin, C. Couture, M. K. Sackett, and G. Boivin, Enhanced lung disease and Th 2 response following human metapneumovirus infection in mice immunized with the inactivated virus, J. Gen. Virol, vol.88, pp.3391-3400, 2007.

R. A. Karron, U. J. Buchholz, and P. L. Collins, Live-attenuated respiratory syncytial virus vaccines, Curr Top Microbiol. Immunol, vol.372, pp.259-284, 2013.

J. Papenburg, J. Carbonneau, S. Isabel, M. G. Bergeron, J. V. Williams et al., Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade, J. Clin. Virol, vol.58, pp.541-547, 2013.

B. Huck, G. Scharf, D. Neumann-haefelin, W. Puppe, J. Weigl et al., Novel human metapneumovirus sublineage, Emerg. Infect. Dis, vol.12, pp.147-150, 2006.

T. C. Peret, G. Boivin, Y. Li, M. Couillard, C. Humphrey et al., Characterization of human metapneumoviruses isolated from patients in North America, J. Infect. Dis, vol.185, pp.1660-1663, 2002.

M. E. Hamelin, Y. Abed, and G. Boivin, Human metapneumovirus: a new player among respiratory viruses, Clin. Infect. Dis, vol.38, pp.983-990, 2004.

M. Nidaira, K. Taira, H. Hamabata, T. Kawaki, K. Gushi et al., Molecular epidemiology of human metapneumovirus from 2009 to 2011 in Okinawa, Japan. Jpn. J. Infect. Dis, vol.65, pp.337-340, 2012.

S. Biacchesi, M. H. Skiadopoulos, G. Boivin, C. T. Hanson, B. R. Murphy et al., Genetic diversity between human metapneumovirus subgroups, Virology, vol.315, pp.1-9, 2003.

B. G. Van-den-hoogen, T. M. Bestebroer, A. D. Osterhaus, and R. A. Fouchier, Analysis of the genomic sequence of a human metapneumovirus, Virology, vol.295, pp.119-132, 2002.

M. H. Skiadopoulos, S. Biacchesi, U. J. Buchholz, E. Amaro-carambot, S. R. Surman et al., Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity, Virology, vol.345, pp.492-501, 2006.

R. G. Cox and J. V. Williams, Breaking in: Human metapneumovirus fusion and entry, vol.5, pp.192-210, 2013.

P. Adamson, S. Thammawat, G. Muchondo, T. Sadlon, and D. Gordon, Diversity in glycosaminoglycan binding amongst hMPV G protein lineages, vol.4, pp.3785-3803, 2012.

R. G. Cox, S. B. Livesay, M. Johnson, M. D. Ohi, and J. V. Williams, The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins, J. Virol, vol.86, pp.12148-12160, 2012.

A. Chang, C. Masante, U. J. Buchholz, and R. E. Dutch, Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate, J. Virol, vol.86, pp.3230-3243, 2012.

G. Cseke, M. S. Maginnis, R. G. Cox, S. J. Tollefson, A. B. Podsiad et al., Integrin ?v?1 promotes infection by human metapneumovirus, vol.106, pp.1566-1571, 2009.

X. Bao, T. Liu, Y. Shan, K. Li, R. P. Garofalo et al., Human metapneumovirus glycoprotein G inhibits innate immune responses, PLoS Pathog, 2008.

D. Kolli, X. Bao, T. Liu, C. Hong, T. Wang et al., Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells, J. Immunol, vol.187, pp.47-54, 2011.

X. Bao, D. Kolli, J. Ren, T. Liu, R. P. Garofalo et al., Human Metapneumovirus Glycoprotein G Disrupts Mitochondrial Signaling in Airway Epithelial Cells, PLoS ONE, vol.8, 2013.

X. Bao, D. Kolli, T. Liu, Y. Shan, R. P. Garofalo et al., Human metapneumovirus small hydrophobic protein inhibits NF-?B transcriptional activity, J. Virol, vol.82, pp.8224-8229, 2008.

C. Masante, F. El-najjar, A. Chang, A. Jones, C. L. Moncman et al., The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity, J. Virol, vol.88, pp.6423-6433, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01101081

S. Biacchesi, M. H. Skiadopoulos, L. Yang, E. W. Lamirande, K. C. Tran et al., Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: Deletion of G yields a promising vaccine candidate, J. Virol, vol.78, pp.12877-12887, 2004.

S. Biacchesi, M. H. Skiadopoulos, K. C. Tran, B. R. Murphy, P. L. Collins et al., Recovery of human metapneumovirus from cDNA: Optimization of growth in vitro and expression of additional genes, Virology, vol.321, pp.247-259, 2004.

L. Aerts, M. H. Cavanagh, J. Dubois, J. Carbonneau, C. Rheaume et al., Effect of in vitro syncytium formation on the severity of human metapneumovirus disease in a murine model, PLoS ONE, vol.10, 2015.

J. Dubois, M. H. Cavanagh, O. Terrier, M. E. Hamelin, B. Lina et al., Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia, J. Gen. Virol, vol.98, pp.1174-1180, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01953696

N. Nao, K. Sato, J. Yamagishi, M. Tahara, Y. Nakatsu et al., Consensus and variations in cell line specificity among human metapneumovirus strains, PLoS ONE, vol.14, 2019.

V. Mas, S. Herfst, A. D. Osterhaus, R. A. Fouchier, and J. A. Melero, Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: Implications for the virus replication cycle, J. Virol, vol.85, pp.12650-12661, 2011.

S. Herfst, V. Mas, L. S. Ver, R. J. Wierda, A. D. Osterhaus et al., Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon, J. Virol, vol.82, pp.8891-8895, 2008.

V. B. Le, J. Dubois, C. Couture, M. H. Cavanagh, O. Uyar et al., Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice, PLoS Pathog, vol.15, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02165995

M. E. Hamelin, K. Yim, K. H. Kuhn, R. P. Cragin, M. Boukhvalova et al., Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats, J. Virol, vol.79, pp.8894-8903, 2005.

J. Meng, A. L. Hotard, M. G. Currier, S. Lee, C. C. Stobart et al., Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein, J. Virol, vol.90, pp.245-253, 2015.

N. De-lamballerie, C. Pizzorno, A. Dubois, J. Julien, T. Padey et al., Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia, Sci. Rep, vol.9, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02322305

S. Mayor, Acute respiratory infections are world's third leading cause of death, BMJ, vol.341, p.6360, 2010.

J. Vekemans, V. Moorthy, B. Giersing, M. Friede, J. Hombach et al., Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics, 2018.

R. A. Karron, J. San-mateo, K. Wanionek, P. L. Collins, and U. J. Buchholz, Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children, J. Pediatr. Infect. Dis. Soc, vol.7, pp.86-89, 2017.

S. Biacchesi, Q. N. Pham, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins et al., Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates, J. Virol, vol.79, pp.12608-12613, 2005.

N. Bastien, L. Liu, D. Ward, T. Taylor, and Y. Li, Genetic variability of the G glycoprotein gene of human metapneumovirus, J. Clin. Microbiol, vol.42, pp.3532-3537, 2004.

R. Piyaratna, S. J. Tollefson, and J. Williams, Genomic analysis of four human metapneumovirus prototypes, Virus Res, vol.160, 0205.

O. Schildgen, A. Simon, and J. Williams, Animal models for human metapneumovirus (HMPV) infections. Veterinary research, vol.38, pp.117-126, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00902848

L. Sun, T. T. Cornell, A. Levine, A. A. Berlin, V. Hinkovska-galcheva et al., Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation, Clin. Exp. Immunol, vol.172, pp.263-279, 2013.

V. V. Malashchenko, M. E. Meniailo, V. A. Shmarov, N. D. Gazatova, O. B. Melashchenko et al., Direct anti-inflammatory effects of granulocyte colony-stimulating factor (G-CSF) on activation and functional properties of human T cell subpopulations in vitro, Cell. Immunol, vol.325, pp.23-32, 2018.

H. W. Kim, J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock et al., Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am. J. Epidemiol, vol.89, pp.422-434, 1969.